Cargando…

Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH‐AF Meta‐Analysis Study Cohort

BACKGROUND: The objective was to explore the efficacy of ablation lesion sets in addition to pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation. The optimal strategy for catheter ablation of paroxysmal atrial fibrillation is debated. METHODS AND RESULTS: The SMASH‐AF (Systematic Revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cluckey, Andrew, Perino, Alexander C., Yunus, Fahd N., Leef, George C., Askari, Mariam, Heidenreich, Paul A., Narayan, Sanjiv M., Wang, Paul J., Turakhia, Mintu P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405732/
https://www.ncbi.nlm.nih.gov/pubmed/30587059
http://dx.doi.org/10.1161/JAHA.118.009976
_version_ 1783401149436526592
author Cluckey, Andrew
Perino, Alexander C.
Yunus, Fahd N.
Leef, George C.
Askari, Mariam
Heidenreich, Paul A.
Narayan, Sanjiv M.
Wang, Paul J.
Turakhia, Mintu P.
author_facet Cluckey, Andrew
Perino, Alexander C.
Yunus, Fahd N.
Leef, George C.
Askari, Mariam
Heidenreich, Paul A.
Narayan, Sanjiv M.
Wang, Paul J.
Turakhia, Mintu P.
author_sort Cluckey, Andrew
collection PubMed
description BACKGROUND: The objective was to explore the efficacy of ablation lesion sets in addition to pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation. The optimal strategy for catheter ablation of paroxysmal atrial fibrillation is debated. METHODS AND RESULTS: The SMASH‐AF (Systematic Review and Meta‐analysis of Ablation Strategy Heterogeneity in Atrial Fibrillation) study cohort includes trials and observational studies identified in PubMed, Scopus, and Cochrane databases from January 1 1990, to August 1, 2016. We included studies reporting single procedure paroxysmal atrial fibrillation ablation success rates. Exclusion criteria included insufficient reporting of outcomes, ablation strategies that were not prespecified and uniform, and a sample size of fewer than 40 patients. We analyzed lesion sets performed in addition to PVI (PVI plus) using multivariable random‐effects meta‐regression to control for patient, study, and procedure characteristics. The analysis included 145 total studies with 23 263 patients (PVI‐only cohort: 115 studies, 148 treatment arms, 16 500 patients; PVI plus cohort: 39 studies; 46 treatment arms, 6763 patients). PVI plus studies, as compared with PVI‐only studies, included younger patients (56.7 years versus 58.8 years, P=0.001), fewer women (27.2% versus 32.0% women, P=0.002), and were more methodologically rigorous with longer follow‐up (29.5 versus 17.1 months, P 0.004) and more randomization (19.4% versus 11.8%, P<0.001). In multivariable meta‐regression, PVI plus studies were associated with improved success (7.6% absolute improvement [95% CI, 2.6–12.5%]; P<0.01, I (2)=88%), specifically superior vena cava isolation (4 studies, 4 treatment arms, 1392 patients; 15.1% absolute improvement [95% CI, 2.3–27.9%]; P 0.02, I (2)=87%). However, residual heterogeneity was large. CONCLUSIONS: Across the paroxysmal atrial fibrillation ablation literature, PVI plus ablation strategies were associated with incremental improvements in success rate. However, large residual heterogeneity complicates evidence synthesis.
format Online
Article
Text
id pubmed-6405732
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64057322019-03-21 Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH‐AF Meta‐Analysis Study Cohort Cluckey, Andrew Perino, Alexander C. Yunus, Fahd N. Leef, George C. Askari, Mariam Heidenreich, Paul A. Narayan, Sanjiv M. Wang, Paul J. Turakhia, Mintu P. J Am Heart Assoc Systematic Review and Meta‐analysis BACKGROUND: The objective was to explore the efficacy of ablation lesion sets in addition to pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation. The optimal strategy for catheter ablation of paroxysmal atrial fibrillation is debated. METHODS AND RESULTS: The SMASH‐AF (Systematic Review and Meta‐analysis of Ablation Strategy Heterogeneity in Atrial Fibrillation) study cohort includes trials and observational studies identified in PubMed, Scopus, and Cochrane databases from January 1 1990, to August 1, 2016. We included studies reporting single procedure paroxysmal atrial fibrillation ablation success rates. Exclusion criteria included insufficient reporting of outcomes, ablation strategies that were not prespecified and uniform, and a sample size of fewer than 40 patients. We analyzed lesion sets performed in addition to PVI (PVI plus) using multivariable random‐effects meta‐regression to control for patient, study, and procedure characteristics. The analysis included 145 total studies with 23 263 patients (PVI‐only cohort: 115 studies, 148 treatment arms, 16 500 patients; PVI plus cohort: 39 studies; 46 treatment arms, 6763 patients). PVI plus studies, as compared with PVI‐only studies, included younger patients (56.7 years versus 58.8 years, P=0.001), fewer women (27.2% versus 32.0% women, P=0.002), and were more methodologically rigorous with longer follow‐up (29.5 versus 17.1 months, P 0.004) and more randomization (19.4% versus 11.8%, P<0.001). In multivariable meta‐regression, PVI plus studies were associated with improved success (7.6% absolute improvement [95% CI, 2.6–12.5%]; P<0.01, I (2)=88%), specifically superior vena cava isolation (4 studies, 4 treatment arms, 1392 patients; 15.1% absolute improvement [95% CI, 2.3–27.9%]; P 0.02, I (2)=87%). However, residual heterogeneity was large. CONCLUSIONS: Across the paroxysmal atrial fibrillation ablation literature, PVI plus ablation strategies were associated with incremental improvements in success rate. However, large residual heterogeneity complicates evidence synthesis. John Wiley and Sons Inc. 2018-12-27 /pmc/articles/PMC6405732/ /pubmed/30587059 http://dx.doi.org/10.1161/JAHA.118.009976 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Systematic Review and Meta‐analysis
Cluckey, Andrew
Perino, Alexander C.
Yunus, Fahd N.
Leef, George C.
Askari, Mariam
Heidenreich, Paul A.
Narayan, Sanjiv M.
Wang, Paul J.
Turakhia, Mintu P.
Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH‐AF Meta‐Analysis Study Cohort
title Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH‐AF Meta‐Analysis Study Cohort
title_full Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH‐AF Meta‐Analysis Study Cohort
title_fullStr Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH‐AF Meta‐Analysis Study Cohort
title_full_unstemmed Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH‐AF Meta‐Analysis Study Cohort
title_short Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH‐AF Meta‐Analysis Study Cohort
title_sort efficacy of ablation lesion sets in addition to pulmonary vein isolation for paroxysmal atrial fibrillation: findings from the smash‐af meta‐analysis study cohort
topic Systematic Review and Meta‐analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405732/
https://www.ncbi.nlm.nih.gov/pubmed/30587059
http://dx.doi.org/10.1161/JAHA.118.009976
work_keys_str_mv AT cluckeyandrew efficacyofablationlesionsetsinadditiontopulmonaryveinisolationforparoxysmalatrialfibrillationfindingsfromthesmashafmetaanalysisstudycohort
AT perinoalexanderc efficacyofablationlesionsetsinadditiontopulmonaryveinisolationforparoxysmalatrialfibrillationfindingsfromthesmashafmetaanalysisstudycohort
AT yunusfahdn efficacyofablationlesionsetsinadditiontopulmonaryveinisolationforparoxysmalatrialfibrillationfindingsfromthesmashafmetaanalysisstudycohort
AT leefgeorgec efficacyofablationlesionsetsinadditiontopulmonaryveinisolationforparoxysmalatrialfibrillationfindingsfromthesmashafmetaanalysisstudycohort
AT askarimariam efficacyofablationlesionsetsinadditiontopulmonaryveinisolationforparoxysmalatrialfibrillationfindingsfromthesmashafmetaanalysisstudycohort
AT heidenreichpaula efficacyofablationlesionsetsinadditiontopulmonaryveinisolationforparoxysmalatrialfibrillationfindingsfromthesmashafmetaanalysisstudycohort
AT narayansanjivm efficacyofablationlesionsetsinadditiontopulmonaryveinisolationforparoxysmalatrialfibrillationfindingsfromthesmashafmetaanalysisstudycohort
AT wangpaulj efficacyofablationlesionsetsinadditiontopulmonaryveinisolationforparoxysmalatrialfibrillationfindingsfromthesmashafmetaanalysisstudycohort
AT turakhiamintup efficacyofablationlesionsetsinadditiontopulmonaryveinisolationforparoxysmalatrialfibrillationfindingsfromthesmashafmetaanalysisstudycohort